Press Release Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026 4 hours ago
Press Release Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury Aug 3
Press Release Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 21